Upgrade to SI Premium - Free Trial

Zealand Pharma (ZEAL)

17.59 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes September 15, 2026 7:00 AM - BizWire Zealand Pharma - Transactions related to share buy-back program (week 37, 2026) September 14, 2026 11:00 AM - StreetInsider Zealand Pharma increases its share capital as a result of the exercise of employee warrants September 10, 2026 11:00 AM - StreetInsider Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference September 9, 2026 11:00 AM - StreetInsider Barclays Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Equalweight September 8, 2026 2:48 AM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 36, 2026) September 7, 2026 11:00 AM - StreetInsider Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) September 2, 2026 11:00 AM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) August 31, 2026 11:00 AM - StreetInsider Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons August 28, 2026 4:00 PM - Globe NewsWire Zealand Pharma – Notification of holding of treasury shares August 24, 2026 11:05 AM - Globe NewsWire Zealand Pharma - Transactions related to share buy-back program (week 34, 2026) August 24, 2026 11:00 AM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 33, 2026) August 17, 2026 11:00 AM - StreetInsider Zealand Pharma Announces Financial Results for the First Half of 2026 August 13, 2026 1:00 AM - StreetInsider Zealand Pharma sells rusfertide royalty rights to Royalty Pharma for $100M August 12, 2026 4:07 PM - StreetInsider Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide August 12, 2026 4:05 PM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 32, 2026) August 10, 2026 11:00 AM - StreetInsider Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results August 6, 2026 11:00 AM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 31, 2026) August 3, 2026 11:00 AM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 30, 2026) July 27, 2026 11:00 AM - StreetInsider Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons July 20, 2026 4:00 PM - StreetInsider Zealand Pharma: Transactions related to share buy-back program (week 29, 2026) July 20, 2026 11:00 AM - StreetInsider Jefferies Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Hold July 14, 2026 1:58 AM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 28, 2026) July 13, 2026 11:00 AM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 27, 2026) July 6, 2026 11:00 AM - StreetInsider Total number of shares and voting rights in Zealand Pharma as of June 30, 2026 June 30, 2026 4:01 PM - StreetInsider Capital Group's stake in Zealand Pharma drops below 5% June 30, 2026 4:00 PM - StreetInsider Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. June 30, 2026 4:00 PM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 26, 2026) June 29, 2026 11:00 AM - StreetInsider Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons June 22, 2026 4:00 PM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 25, 2026) June 22, 2026 11:00 AM - StreetInsider Full Article List